Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis.

@article{Liang2015ChemokineRC,
  title={Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis.},
  author={Jin-xiao Liang and Wei Gao and Yong Liang and Xin-ming Zhou},
  journal={International journal of clinical and experimental medicine},
  year={2015},
  volume={8 4},
  pages={
          5163-74
        }
}
The chemokine receptor CXCR4 is a G protein-coupled receptor that plays an important role in several biological processes, such as trafficking and homeostasis of immune cells (like T lymphocytes), alteration of cell skeleton rearrangement and cell migration. To investigate whether the CXCR4 protein impacts on lung cancer prognosis, a meta-analysis was performed. Our meta-analysis study involved 2,037 lung cancer patients from 24 studies by a comprehensive search from PubMed, Embase and CNKI… CONTINUE READING
View PDF

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients

Masakazu Katsura, Fumihiro Shoji, +7 authors Yoshihiko Maehara
  • Cancer science
  • 2018
VIEW 7 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338

Serena Pollino, Emanuela Palmerini, +6 authors L. Pazzaglia
  • Journal of bone oncology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells

Lin Wang, Lin Shi, +4 authors Di Ge
  • Journal of Physiology and Biochemistry
  • 2018

CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)

Ori Wald
  • Journal of clinical medicine
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4

Liru He, Haixia Deng, +8 authors Dan Xie
  • Cancer communications
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.

Ravi Salgia, John R Stille, +6 authors David Robert Spigel
  • Lung cancer
  • 2017

Prognostic and predictive value of circulating tumor cells and CXCR 4 expression as biomarkers for a CXCR 4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer : exploratory analysis of a phase II study

Ravi Salgia, R. Waide Weaver, +18 authors David R. Spigel
  • 2017

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

Ravi Salgia, R. Waide Weaver, +17 authors David Robert Spigel
  • Investigational New Drugs
  • 2017

Synthesis & Evaluation Of Thiophene Derivatives As CXCR4 Antagonists

García, Francisco Javier
  • 2017

CXCR 4 expression as a predictive biomarker for esophageal cancer

Yanmei Ma, Jianxiang Zhang, J Zhang
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 48 REFERENCES

Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Yoshihiro Minamiya, Hajime Saito, +5 authors Junichi Ogawa
  • Lung cancer
  • 2010
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Original Article Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer

Yanlei Li, Yao Shen, +3 authors Xiaofei Qiu
  • 2014
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.

Alya A Al Zobair, Barrak F Al Obeidy, +8 authors Yunfeng Zhou
  • Oncology reports
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Expressions and significance of CXCR4 and CCR7 chemokine receptor in lung cancer

SB Wang, H Zhou, ZT Li, WK Cao, QZ. Han
  • Chin J Gen Prac
  • 2012
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Giulia Bertolini, L Roz, +16 authors Gabriella Sozzi
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2009
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Regulation of cellular proliferation, cytoskele- CXCR4 and lung cancer prognosis

T Kijima, G Maulik, +6 authors R. Salgia
  • Int J Clin Exp Med
  • 2015
VIEW 2 EXCERPTS

Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.

Phoebe Yang, S.-X. Liang, +5 authors Guo-jun Zhang
  • Current molecular medicine
  • 2014
VIEW 1 EXCERPT

Clinical significance of TFPI-2 and CXCR4 expression in non-small cell lung cancer

T Ji, SB Zhu, +3 authors GL. Yin
  • Chin J Clin Healthc
  • 2014
VIEW 3 EXCERPTS

Expression and clinical significance of EGFR, HER2 and CXCR4 in non-small cell lung cancer

L Liu, Y Lv, Y Wang, XL. Ren
  • Prog Modern Biomed
  • 2014
VIEW 3 EXCERPTS

The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis

Cheng-Fei Liu, Shu-yan Liu, +6 authors Ke Li
  • PloS one
  • 2014
VIEW 1 EXCERPT